63 results
DEFA14A
XLO
Xilio Therapeutics Inc
25 Apr 24
Additional proxy soliciting materials
4:10pm
Materials
Soliciting Material under §240.14a-12
XILIO THERAPEUTICS, INC.
(Name of registrant as specified in its charter)
(Name of person(s) filing … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a–6(i)(1) and 0–11
Your Vote Counts! *Please check
8-K
EX-10.1
wb44z
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
mcgl2jrb z8cpmmo
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-10.1
p4t2kf9t gk
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
DEFA14A
046i5
25 Apr 23
Additional proxy soliciting materials
4:10pm
8-K
EX-3.1
yiguvk16381lvri6k8f
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
8-K
24juw64xq 3d
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
ob6rx8ar
3 Apr 23
Departure of Directors or Certain Officers
4:05pm